Manulife (Manufacturers Life Insurance)’s Caris Life Sciences CAI Stock Holding History
Bought
Maintained
Sold
Other funds holding CAI
JHWEPV
SSP
B
PC
VPM
Manulife (Manufacturers Life Insurance)'s CAI Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) increased its Caris Life Sciences (CAI) stake by 51% in Q1 2026, buying an estimated $1.13M and bringing the position to 153,512 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1372.
Manulife (Manufacturers Life Insurance) first reported a position in CAI in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.33M in Q3 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 153,512 shares of Caris Life Sciences worth $2.74M as of Q1 2026.
- Manulife (Manufacturers Life Insurance) bought 51,696 Caris Life Sciences shares in Q1 2026, an estimated $1.13M.
- Caris Life Sciences made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1372 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Caris Life Sciences in Q2 2025 and has held it in 4 quarters since.
- Manulife (Manufacturers Life Insurance)'s Caris Life Sciences position peaked at $3.33M in Q3 2025.
- 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.